Found 20 results
Author Title [ Type(Desc)] Year
Filters: Keyword is Virus Replication  [Clear All Filters]
Journal Article
H. M. Moulton, Fletcher, S., Neuman, B. W., McClorey, G., Stein, D. A., Abes, S., Wilton, S. D., Buchmeier, M. J., Lebleu, B., and Iversen, P. L., “Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.”, Biochemical Society transactions, vol. 35, no. Pt 4, pp. 826-8, 2007.
D. L. Swenson, Warfield, K. L., Warren, T. K., Lovejoy, C., Hassinger, J. N., Ruthel, G., Blouch, R. E., Moulton, H. M., Weller, D. D., Iversen, P. L., and Bavari, S., “Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection.”, Antimicrobial agents and chemotherapy, vol. 53, no. 5, pp. 2089-99, 2009.
G. Green, Johnson, S. M., Costello, H., Brakel, K., Harder, O., Oomens, A. G., Peeples, M. E., Moulton, H. M., and Niewiesk, S., “CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.”, J Virol, vol. 95, no. 16, p. e0001021, 2021.
C. Lupfer and Pastey, M., “Decreased replication of human respiratory syncytial virus treated with the proteasome inhibitor MG-132.”, Virus research, vol. 149, no. 1, pp. 36-41, 2010.
B. W. Neuman, Bederka, L. H., Stein, D. A., Ting, J. P. C., Moulton, H. M., and Buchmeier, M. J., “Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.”, Antimicrob Agents Chemother, vol. 55, no. 10, pp. 4631-8, 2011.
B. W. Neuman, Bederka, L. H., Stein, D. A., Ting, J. P. C., Moulton, H. M., and Buchmeier, M. J., “Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.”, Antimicrobial agents and chemotherapy, vol. 55, no. 10, pp. 4631-8, 2011.
L. Louis Seifert, Si, C., Saha, D., Sadic, M., de Vries, M., Ballentine, S., Briley, A., Wang, G., Valero-Jimenez, A. M., Mohamed, A., Schaefer, U., Moulton, H. M., García-Sastre, A., Tripathi, S., Rosenberg, B. R., and Dittmann, M., “The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response.”, PLoS Pathog, vol. 15, no. 11, p. e1007634, 2019.
G. - C. Perng, Maguen, B., Jin, L., Mott, K. R., Osorio, N., Slanina, S. M., Yukht, A., Ghiasi, H., Nesburn, A. B., Inman, M., Henderson, G., Jones, C., and Wechsler, S. L., “A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.”, Journal of virology, vol. 76, no. 3, pp. 1224-35, 2002.
D. Bestle, Limburg, H., Kruhl, D., Harbig, A., Stein, D. A., Moulton, H. M., Matrosovich, M., Abdelwhab, E. M., Stech, J., and Böttcher-Friebertshäuser, E., “Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.”, J Virol, vol. 95, no. 20, p. e0090621, 2021.
L. Jin, Perng, G. - C., Mott, K. R., Osorio, N., Naito, J., Brick, D. J., Carpenter, D., Jones, C., and Wechsler, S. L., “A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse.”, Journal of virology, vol. 79, no. 19, pp. 12286-95, 2005.
S. Mohapatra, Park, S. J., Boyapalle, S., Pastey, M., Graham, B. S., and Blanck, G., “Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells.”, Acta virologica, vol. 53, no. 3, pp. 207-11, 2009.
J. Yuan, Stein, D. A., Lim, T., Qiu, D., Coughlin, S., Liu, Z., Wang, Y., Blouch, R., Moulton, H. M., Iversen, P. L., and Yang, D., “Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.”, Journal of virology, vol. 80, no. 23, pp. 11510-9, 2006.
Y. - J. Zhang, Wang, K. - Y., Stein, D. A., Patel, D., Watkins, R., Moulton, H. M., Iversen, P. L., and Matson, D. O., “Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.”, Antiviral research, vol. 73, no. 1, pp. 12-23, 2007.
K. Rosenke, Leventhal, S., Moulton, H. M., Hatlevig, S., Hawman, D., Feldmann, H., and Stein, D. A., “Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.”, J Antimicrob Chemother, vol. 76, no. 2, pp. 413-417, 2021.
L. Jin, Perng, G. - C., Carpenter, D., Mott, K. R., Osorio, N., Naito, J., Brick, D. J., Jones, C., and Wechsler, S. L., “Reactivation phenotype in rabbits of a herpes simplex virus type 1 mutant containing an unrelated antiapoptosis gene in place of latency-associated transcript.”, Journal of neurovirology, vol. 13, no. 1, pp. 78-84, 2007.
L. Martin-Sancho, Tripathi, S., Rodriguez-Frandsen, A., Pache, L., Sanchez-Aparicio, M., McGregor, M. J., Haas, K. M., Swaney, D. L., Nguyen, T. T., Mamede, J. I., Churas, C., Pratt, D., Rosenthal, S. B., Riva, L., Nguyen, C., Beltran-Raygoza, N., Soonthornvacharin, S., Wang, G., Jimenez-Morales, D., De Jesus, P. D., Moulton, H. M., Stein, D. A., Chang, M. W., Benner, C., Ideker, T., Albrecht, R. A., Hultquist, J. F., Krogan, N. J., García-Sastre, A., and Chanda, S. K., “Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy.”, Nat Microbiol, vol. 6, no. 10, pp. 1319-1333, 2021.
T. L. Gower, Pastey, M., Peeples, M. E., Collins, P. L., McCurdy, L. H., Hart, T. K., Guth, A., Johnson, T. R., and Graham, B. S., “RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.”, Journal of virology, vol. 79, no. 9, pp. 5326-36, 2005.
D. Bestle, Heindl, M. Ruth, Limburg, H., van, T. Van Lam, Pilgram, O., Moulton, H. M., Stein, D. A., Hardes, K., Eickmann, M., Dolnik, O., Rohde, C., Klenk, H. - D., Garten, W., Steinmetzer, T., and Böttcher-Friebertshäuser, E., “TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.”, Life Sci Alliance, vol. 3, no. 9, 2020.
H. Limburg, Harbig, A., Bestle, D., Stein, D. A., Moulton, H. M., Jaeger, J., Janga, H., Hardes, K., Koepke, J., Schulte, L., Koczulla, A. Rembert, Schmeck, B., Klenk, H. - D., and Böttcher-Friebertshäuser, E., “TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.”, J Virol, vol. 93, no. 21, 2019.
C. Lupfer, Patton, K. M., and Pastey, M., “Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.”, Toxicology, vol. 268, no. 1-2, pp. 25-30, 2010.